» Articles » PMID: 36342670

Costs of Management of Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis

Overview
Journal J Glob Health
Date 2022 Nov 7
PMID 36342670
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute respiratory infections (ARIs) accounted for an estimated 3.9 million deaths worldwide in 2015, of which 56% occurred in adults aged 60 years or older. We aimed to identify the cost of ARI management in older adults (≥50 years) in order to develop an evidence base to assist decision-making for resource allocation and inform clinical practice.

Methods: We searched 8 electronic databases including Global Health, Medline and EMBASE for studies published between January 1, 2000 and December 31, 2021. Total management costs per patient per ARI episode were extracted and meta-analysis was conducted by World Health Organization (WHO) region and World Bank income level. All costs were converted and inflated to Euros (€) (2021 average exchange rate). The quality of included studies and the potential risk of bias were evaluated.

Results: A total of 42 publications were identified for inclusion, reporting cost data for 8 082 752 ARI episodes in older adults across 20 countries from 2001 to 2021. The majority (86%) of studies involved high-income countries based in Europe, North America and Western Pacific. The mean cost per episode was €17 803.9 for inpatient management and €128.9 for outpatient management. Compared with costs reported for patients aged <65 years, inpatient costs were €154.1, €7 018.8 and €8 295.6 higher for patients aged 65-74 years, 75-84 years and over 85 years. ARI management of at-risk patients with comorbid conditions and patients requiring higher level of care, incurred substantially higher costs for hospitalization: €735.9 and €1317.3 respectively.

Conclusions: ARIs impose a substantial economic burden on health systems, governments, patients and societies. This study identified high ARI management costs in older adults, reinforcing calls for investment by global health players to quantify and address the scale of the challenge. There are large gaps in data availability from low-income countries, especially from South East Asia and Africa regions.

Citing Articles

Burden and Economic Impact of Respiratory Viral Infections in Adults Aged 60 and Older: A Focus on RSV.

Pelaez A, Jimeno Ruiz S, Villarreal M, Gil M, Gutierrez I, Sanz M Diseases. 2025; 13(2).

PMID: 39997042 PMC: 11854486. DOI: 10.3390/diseases13020035.


Management cost of acute respiratory infections in older adults in China: A systematic review and meta-analysis.

Xu X, Zhang T, Miao Y, Li X, Li Y J Glob Health. 2024; 14:04165.

PMID: 39388681 PMC: 11466502. DOI: 10.7189/jogh.14.04165.


A Structured Narrative Literature Review of the Broader Value of Adult Immunisation Programmes.

El Banhawi H, Bell E, Neri M, Brassel S, Chowdhury S, Steuten L Vaccines (Basel). 2024; 12(8).

PMID: 39203978 PMC: 11359156. DOI: 10.3390/vaccines12080852.


The validity of single-item measures of health-related quality of life across groups differing in acute respiratory symptom severity.

Smith A, Ware Jr J, Aluko P, Kulasekaran A Qual Life Res. 2024; 33(10):2773-2780.

PMID: 39096424 PMC: 11452483. DOI: 10.1007/s11136-024-03694-0.


Emerging Methods in the Identification of Bacterial Respiratory Tract Pathogens.

Kiaghobadi F, Dehshahri A, Ghasemi Y, Morowvat M Recent Pat Biotechnol. 2024; 19(3):198-209.

PMID: 38967072 DOI: 10.2174/0118722083309510240625085931.


References
1.
Yoon J, Noh J, Choi W, Park J, Suh Y, Song J . Clinical characteristics and disease burden of respiratory syncytial virus infection among hospitalized adults. Sci Rep. 2020; 10(1):12106. PMC: 7374583. DOI: 10.1038/s41598-020-69017-8. View

2.
Tichopad A, Roberts C, Gembula I, Hajek P, Skoczynska A, Hryniewicz W . Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia. PLoS One. 2013; 8(8):e71375. PMC: 3735497. DOI: 10.1371/journal.pone.0071375. View

3.
Ye X, Ma J, Hu B, Gao X, He L, Shen W . Improvement in clinical and economic outcomes with empiric antibiotic therapy covering atypical pathogens for community-acquired pneumonia patients: a multicenter cohort study. Int J Infect Dis. 2015; 40:102-7. DOI: 10.1016/j.ijid.2015.03.012. View

4.
Peytremann-Bridevaux I, Arditi C, Gex G, Bridevaux P, Burnand B . Chronic disease management programmes for adults with asthma. Cochrane Database Syst Rev. 2015; (5):CD007988. PMC: 10640711. DOI: 10.1002/14651858.CD007988.pub2. View

5.
Prasad N, Newbern E, Trenholme A, Thompson M, McArthur C, Wong C . The health and economic burden of respiratory syncytial virus associated hospitalizations in adults. PLoS One. 2020; 15(6):e0234235. PMC: 7289360. DOI: 10.1371/journal.pone.0234235. View